Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
KRAS gene
Fierce Biotech Homepage
Amgen sticks by Lumakras dose as ESMO data boost confidence
Amgen's Paul Burton, M.D., is sticking with the high dose of Lumakras for now after FDA advisers knocked down confirmatory results earlier this year.
Max Bayer
Oct 22, 2023 10:30am
In quarterly earnings report, Amgen shows off Lumakras launch
Nov 3, 2021 11:50am
Early days, but Lumakras expectations are high, Amgen execs say
Aug 5, 2021 9:50am
Here comes Amgen's Lumakras, but can it stand the test of time?
May 26, 2021 10:00am
Why look for KRAS mutations? New Mirati, Amgen campaigns explain
Apr 12, 2021 9:45am
